Speaker



Hanne Callewaert | CEO, AstriVax Therapeutics

Hanne has 20+ years life science industry experience exhibiting a unique capability to merge operational execution with strategy development. Equipped with a Master in Biomedical Sciences, a PhD in Medical Sciences and a Master in Intellectual Property law and strong global industry experience in large pharmaceutical industry (GSK Vaccines) as well as into smaller biotech environment (Oxurion, Oncurious, AstriVax Therapeutics). She is passionate developer of vaccines, therapeutic, teams and company culture. Executive experience as public company COO and founding biotech CEO. She also enjoys her busy family life as proud mom of four. 


AstriVax Therapeutics

AstriVax Therapeutics is a European based, clinical-stage biopharmaceutical company, founded in 2022 with a strong focus on immunotherapies. The company develops immunotherapy assets by launching self-amplifying live attenuated viral vectors and target antigens, through the Launch-iT platform. We differentiate in the ability to create qualitative effector T-cells with a unique durable profile. We focus on treating early, clearing infections and hence preventing progression into cancer for e.g. HPV. Our future pipeline could encompass oncology and autoimmune diseases as well.

Powered by:
Hyphen Projects   

Let's connect:           
Book a ticket
FAQ
Contact Us
Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
          
 
 

                                    

Keep me informed Download the sponsor brochure


© Copyright 2025 by Hyphen Projects